Medtronic

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Medtronic 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MDT

Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. 

CEO
Geoffrey Straub Martha
CEOGeoffrey Straub Martha
Employees
95,000
Employees95,000
Headquarters
Galway, Galway
HeadquartersGalway, Galway
Founded
2014
Founded2014
Employees
95,000
Employees95,000

MDT Key Statistics

Market cap
118.77B
Market cap118.77B
Price-Earnings ratio
25.58
Price-Earnings ratio25.58
Dividend yield
3.03%
Dividend yield3.03%
Average volume
8.84M
Average volume8.84M
High today
$92.96
High today$92.96
Low today
$91.63
Low today$91.63
Open price
$91.80
Open price$91.80
Volume
4.88M
Volume4.88M
52 Week high
$96.25
52 Week high$96.25
52 Week low
$79.29
52 Week low$79.29

MDT News

CNBC 1d
Medtronic makes two key additions to its board. How activist Elliott can build shareholder value

Activist: Elliott Investment Management Ownership: n/a Average Cost: n/a Activist Commentary: Elliott is a very successful and astute activist investor. The...

Medtronic makes two key additions to its board. How activist Elliott can build shareholder value
Simply Wall St 1d
The Bull Case for Medtronic Could Change Following Board Expansion and Activist Collaboration—Learn Why

Earlier this week, Medtronic plc appointed two new independent directors with deep medical technology experience, expanded its board, and formed two focused com...

The Bull Case for Medtronic Could Change Following Board Expansion and Activist Collaboration—Learn Why
TipRanks 3d
Medtronic price target raised to $96 from $92 at Truist

Truist raised the firm’s price target on Medtronic (MDT) to $96 from $92 and keeps a Hold rating on the shares. The company’s in-line Q1 organic revenue growth...

Analyst ratings

50%

of 36 ratings
Buy
50%
Hold
47.2%
Sell
2.8%

More MDT News

Simply Wall St 3d
Medtronic: Assessing Valuation as Boardroom Shake-Up Signals Strategic Shift and Investor Influence

Certainly! Here is the revised article text with em dashes replaced and formatting improved: If you have been watching Medtronic (MDT) lately, you might have n...

Medtronic: Assessing Valuation as Boardroom Shake-Up Signals Strategic Shift and Investor Influence
Benzinga 4d
Medtronic Has Potential To Pursue Further Divestitures: Analyst

On Tuesday, Medtronic Plc MDT reported second-quarter earnings and announced key board appointments after Elliott Investment Management became the company's lar...

Medtronic Has Potential To Pursue Further Divestitures: Analyst
TipRanks 4d
Medtronic’s Strong Financial Performance and Positive Outlook Justify Buy Rating

Citi analyst Joanne Wuensch reiterated a Buy rating on Medtronic yesterday and set a price target of $99.00. Elevate Your Investing Strategy: Take advantage of...

TipRanks 4d
Positive Outlook for Medtronic Amid Strategic Changes and Elliott Management Investment

Travis Steed, an analyst from Bank of America Securities, reiterated the Buy rating on Medtronic. The associated price target remains the same with $100.00. Ele...

TipRanks 5d
Medtronic Reports Strong Q1 FY26 Results

Medtronic ( (MDT) ) has released its Q1 earnings. Here is a breakdown of the information Medtronic presented to its investors. Elevate Your Investing Strategy:...

TipRanks 5d
Medtronic’s Mixed Performance and Strategic Uncertainty Lead to Hold Rating

William Blair analyst Brandon Vazquez has maintained their neutral stance on MDT stock, giving a Hold rating today. Elevate Your Investing Strategy: Take advant...

Simply Wall St 5d
Medtronic Reports US$8,578 Million Q1 Sales and Appoints New Directors

recently reported its Q1 FY2026 earnings, showing an increase in sales to $8,578 million, while net income saw a slight decline. The company also set its guidan...

Medtronic Reports US$8,578 Million Q1 Sales and Appoints New Directors

People also own

Based on the portfolios of people who own MDT. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.